Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
Số trang: 8
Loại file: pdf
Dung lượng: 504.59 KB
Lượt xem: 12
Lượt tải: 0
Xem trước 1 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
The concerns about the development of adverse events (AEs) in elderly RA patients as a result of age-related changes in drug metabolism and the presence of comorbid illnesses are emphasizing due to increasing prevalence of rheumatoid arthritis (RA) in old age.
Nội dung trích xuất từ tài liệu:
Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
Nội dung trích xuất từ tài liệu:
Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis
Tìm kiếm theo từ khóa liên quan:
BMC Musculoskeletal Disorders Rheumatoid arthritis TNF inhibitor Drug retention rate Comorbid illnessesGợi ý tài liệu liên quan:
-
Neolignans and flavonol glycosides from the leaves of Viburnum lutescens blume
8 trang 37 0 0 -
Risk factors for musculoskeletal pain amongst nurses in Estonia: A cross-sectional study
7 trang 18 0 0 -
10 trang 17 0 0
-
15 trang 16 0 0
-
9 trang 15 0 0
-
10 trang 14 0 0
-
Predicting short stay total hip arthroplasty by use of the timed up and go-test
7 trang 14 0 0 -
Prevalence and risk factors for bone loss in Southern Chinese with rheumatic diseases
12 trang 14 0 0 -
A case of epidemic myalgia with symptoms resembling acute purulent spondylitis and discitis
4 trang 14 0 0 -
11 trang 14 0 0